Kato H, Nakanishi E, Enjyoji K, Hayashi I, Oh-ishi S, Iwanaga S
Department of Biology, Faculty of Science, Kyushu University, Fukuoka.
J Biochem. 1987 Dec;102(6):1389-404. doi: 10.1093/oxfordjournals.jbchem.a122185.
From the homogenate of rat submaxillary gland, two kinds of serine proteinases, named tentatively proteinases A and B, were isolated and their chemical properties and activities toward rat kininogens were examined, in comparison with those of submaxillary kallikrein. Proteinase A with Mr of 28,200 rapidly cleaved high-molecular-weight (HMW) kininogen into a protein of 67 kDa, which retained thiol-proteinase inhibitory activity, but had lost the correcting activity of HMW kininogen on the prolonged clotting time of Fitzgerald trait plasma. It liberated bradykinin from HMW kininogen but did not liberate kinin from T-kininogen and did not degrade T-kininogen. On the other hand, proteinase B with Mr of 30,400 showed a very weak activity for the liberation of kinin from T-kininogen and the cleavage of T-kininogen at pH 8.0. However, the enzyme extensively degraded T-kininogen at pH 4.5. Proteinase B also degraded HMW kininogen at pH 4.5 and pH 8.0, but liberated bradykinin only at pH 8.0. Thiol-proteinase inhibitory activities of HMW kininogen and T-kininogen were inactivated after the incubation with proteinase B at pH 4.5 but not at pH 8.0, while the correcting activity of HMW kininogen on the Fitzgerald trait plasma was inactivated at pH 4.5 and 8.0. The NH2-terminal amino acid sequences of proteinases A and B were different from each other, and distinguishable with those of serine proteinases in rat submaxillary gland so far reported. These results provide evidence that in addition to the known kallikrein, there exist at least two kinds of serine proteinases in rat submaxillary gland, both of which liberate bradykinin from rat HMW kininogen at pH 8.0 and modulate the functional activities of HMW kininogen and T-kininogen, degrading these proteins at pH 8.0 or 4.5.
从大鼠颌下腺匀浆中分离出两种丝氨酸蛋白酶,暂命名为蛋白酶A和蛋白酶B,并研究了它们的化学性质以及对大鼠激肽原的活性,同时与颌下激肽释放酶进行了比较。分子量为28200的蛋白酶A能迅速将高分子量(HMW)激肽原切割成67kDa的蛋白质,该蛋白质保留了巯基蛋白酶抑制活性,但失去了HMW激肽原对菲茨杰拉德特征血浆延长凝血时间的校正活性。它能从HMW激肽原中释放缓激肽,但不能从T-激肽原中释放激肽,也不会降解T-激肽原。另一方面,分子量为30400的蛋白酶B在pH 8.0时对从T-激肽原中释放激肽和切割T-激肽原的活性非常弱。然而,该酶在pH 4.5时能广泛降解T-激肽原。蛋白酶B在pH 4.5和pH 8.0时也能降解HMW激肽原,但仅在pH 8.0时释放缓激肽。HMW激肽原和T-激肽原的巯基蛋白酶抑制活性在pH 4.5与蛋白酶B孵育后失活,但在pH 8.0时不失活,而HMW激肽原对菲茨杰拉德特征血浆的校正活性在pH 4.5和8.0时均失活。蛋白酶A和蛋白酶B的氨基末端氨基酸序列彼此不同,且与迄今报道的大鼠颌下腺丝氨酸蛋白酶的序列不同。这些结果证明,除了已知的激肽释放酶外,大鼠颌下腺中至少还存在两种丝氨酸蛋白酶,它们在pH 8.0时均能从大鼠HMW激肽原中释放缓激肽,并调节HMW激肽原和T-激肽原的功能活性,在pH 8.0或4.5时降解这些蛋白质。